| Literature DB >> 25768731 |
Alexandru Florian Crişan1, Cristian Oancea1, Bogdan Timar2, Ovidiu Fira-Mladinescu1, Voicu Tudorache1.
Abstract
BACKGROUND/Entities:
Mesh:
Year: 2015 PMID: 25768731 PMCID: PMC4358954 DOI: 10.1371/journal.pone.0120573
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Subject characteristics data.
| Parameter | Controls | Stable COPD | AECOPD | p (A vs. B vs. C) |
|---|---|---|---|---|
| No. pts. | 17 | 29 | 17 | |
| No. comorbidities | 1.94 | 2.44 | 2.35 | |
| Age (years) | 61.4 ± 4.0 | 62.2 ± 5.0 | 63.1 ± 4.6 | 0.438 |
| BMI (kg/m2) | 25.3 ± 3.9 | 25.4 ± 3.6 | 24.7 ± 5.7 | 0.867 |
| FVC (%) | 95 [15] | 73 [13] | 58 [10] | <0.001 |
| FEV1 (%) | 95 [18] | 29 [7] | 28 [7] | <0.001 |
| FVC/FEV1 | 79 [9] | 33 [10] | 36 [13] | <0.001 |
| pCO2
| n/a | 41.6 ± 6.8 | 59.2 ± 11.0 | <0.001 |
| pO2
| n/a | 66.1 ± 10.1 | 61.7 ± 11.0 | 0.179 |
* Differences are significant.
§ Variables are Gaussian distributed. Values are presented as mean ± standard deviation. p value was calculated using ANOVA test.
¥ Variables are not-Gaussian distributed. Values are presented as median and [interquartile range]. p was calculated using Kruskal-Wallis test.
Balance parameters, anxiety and depression in the three studied groups.
| A | B | C | ||||
|---|---|---|---|---|---|---|
| Parameter | Controls | Stable COPD | AECOPD | p (A vs. B vs. C) | p (B vs. C) | p (A vs. B) |
| SLS EC (sec) | 8.5 [6.6] | 3.9 [3.4] | 1.5 [2.9] | <0.001 | <0.001 | <0.001 |
| SLS EO (sec) | 31.1 [15.6] | 17.7 [8.4] | 7.2] 4.4] | <0.001 | <0.001 | <0.001 |
| ABC (%) | 97.9 [3.8] | 74.6 [14.8] | 45.5 [35.8] | <0.001 | 0.001 | <0.001 |
| TUG (sec) | 8.6 [2.5] | 12.3 [2.1] | 15.9 [5.8] | <0.001 | 0.002 | <0.001 |
| BBS (points) | 55 [2] | 53 [7] | 44 [6] | <0.001 | <0.001 | 0.445 |
| 6 MWD | 521 [92] | 412 [120] | 214 [187] | <0.001 | <0.001 | 0.032 |
| CAT | 3 [6] | 16 [8] | 30 [10] | <0.001 | <0.001 | <0.001 |
| Anxiety score | 2 [3] | 6 [4] | 9 [5] | <0.001 | 0.002 | <0.001 |
| Depression score | 2 [2] | 7 [5] | 12 [3] | <0.001 | <0.001 | 0.008 |
Variables are not-Gaussian distributed. Values are presented as median and [interquartile range].
* Differences are significant.
§ p value was calculated using Kruskal-Wallis test.
¥ p value was calculated using Mann-Whitney U test.
Correlations between balance tests and inflammatory markers.
| Parameter | ESR | Fibrinogen | C-reactive protein |
|---|---|---|---|
| SLS EC | -0.234 | -0.183 | -0.86 |
| SLS EO | -0.296 | -0.270 | -0.214 |
| ABC | -0.294 | -0.303 | -0.315 |
| TUG | 0.351 | 0.494 | 0.455 |
| BBS | -0.336 | -0.034 | -0.106 |
| 6 MWD | -0.550 | -0.432 | -0.494 |
| CAT | 0.574 | 0.308 | 0.422 |
Correlations strengths were assessed using Spearman’s rank sum correlation coefficient.
* Correlation is significant at α<0.05 level.
** Correlation is significant at α<0.01 level.
Correlations between depression and anxiety and balance parameters and inflammatory markers.
| Parameter | Anxiety | Depression |
|---|---|---|
| SLS EC | -0.364 | -0.419 |
| SLS EO | -0.586 | -0.591 |
| ABC | -0.690 | -0.646 |
| TUG | 0.722 | 0.509 |
| BBS | -0.500 | -0.473 |
| 6 MWD | -0.608 | -0.718 |
| CAT | 0.609 | 0.708 |
| ESR | 0.450 | 0.390 |
| Fibrinogen | 0.338 | 0.305 |
| C-reactive protein | 0.418 | 0.313 |
Correlations strengths were assessed using Spearman’s rank sum correlation coefficient.
* Correlation is significant at α<0.05 level.
** Correlation is significant at α<0.01 level.
Fig 1Correlations between hsCRP values and Berg Balance Score in patients with COPD.
Interrupted lines are representing the 95% confidence interval for the regression line.
Fig 2Correlations between FEV (%) and Berg Balance Score in patients with COPD.
FEV (%)—forced expiratory volume, percent from expected. Interrupted lines are representing the 95% confidence interval for regression line.
Comparison of parameters in relation with the number of falls.
| Number of falls in the previous year | p | |||
|---|---|---|---|---|
| Parameter | 0 | 1 | 2 | |
| Stable COPD (%) | 18 (62.1%) | 11 (37.9%) | 0 (0%) | 0.001 |
| AE COPD (%) | 4 (23.5%) | 7 (41.2%) | 6 (35.3%) | |
| SLS EC | 3.3 [4.1] | 3.3 [3.3] | 0.7 [2.8] | 0.032 |
| SLS EO | 15.9 [7.1] | 13.4 [14.2] | 6.4 [5.8] | 0.005 |
| ABC | 74.4 [13.7] | 66.6 [31.9] | 36.8 [33.4] | 0.006 |
| TUG | 12.0 [2.7] | 13.3 [2.9] | 17.4 [6.8] | 0.002 |
| BBS | 52.5 [7] | 48.5 [10] | 44.5 [6] | 0.026 |
| 6 MWD | 438.5 [105] | 327.5 [179] | 157 [167] | <0.001 |
| CAT | 15.5 [10] | 23 [13] | 33 [6] | <0.001 |
| Anxiety score | 6 [3] | 8 [6] | 9.5 [9] | 0.024 |
| Depression score | 7 [5] | 12 [6] | 12 [2] | 0.005 |
Note: the number of falls was only assessed for patients with stable and AECOPD, and not for controls.
§ Data is presented as number of individuals and (percentage). p value was calculated with chi-square for trend test.
¥ Data is presented as median and [interquartile range]. p value was calculated with Kruskal-Wallis test.